Nutex Health
NUTX
Nutex Health (NUTX) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $9.38
- EPS estimate
- $4.95
- EPS surprise
- +89.34%
- Revenue surprise
- −1.99%
- Revenue
- $210.8M
- Revenue estimate
- $215.0M
- Reported
- Aug 6, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $4.95 | $9.38 | +89.34% | $210.8M | SEC |
| Q1 2026 | Apr 30, 2026 | $3.99 | $6.52 | +63.27% | $216.5M | SEC |
| Q4 2025 | Mar 5, 2026 | $5.56 | $3.11 | −44.03% | $151.7M | SEC |
| Q2 2025 | Aug 14, 2025 | −$1.43 | −$2.95 | −105.82% | $244.0M | SEC |
| Q1 2025 | May 13, 2025 | $3.04 | $2.56 | −15.88% | $211.8M | SEC |
| Q4 2024 | Mar 31, 2025 | −$0.12 | $11.12 | +9118.65% | $257.6M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.24 | −$1.72 | −616.67% | $78.8M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.29 | −$0.07 | +75.86% | $76.1M | SEC |
| Q1 2024 | May 9, 2024 | $0.00 | −$0.10 | +0.00% | $67.5M | SEC |
| Q4 2023 | Mar 28, 2024 | $0.00 | −$7.50 | +0.00% | $69.7M | SEC |
| Q3 2023 | Nov 9, 2023 | −$0.75 | −$1.50 | −100.00% | $62.7M | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.75 | −$1.50 | −100.00% | $58.9M | SEC |
| Q1 2023 | May 15, 2023 | −$2.25 | −$1.50 | +33.33% | $56.3M | SEC |
| Q4 2022 | Mar 2, 2023 | −$2.25 | −$3.00 | −33.33% | $53.7M | SEC |
| Q3 2022 | Nov 18, 2022 | $0.00 | −$94.50 | +0.00% | $28.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Nutex Health (NUTX) last report earnings?
Nutex Health last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did NUTX beat earnings estimates?
Yes. Nutex Health reported EPS of $9.38 for Q2 2026 against a $4.95 estimate — a 89.34% beat.
How much revenue did NUTX report last quarter?
Nutex Health reported $210.8M in revenue for Q2 2026, against a consensus estimate of $215.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.